Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CEO

Chief Financial Officer

CEO & President

EVP Neuroscience Product Dev.

Chief Medical Officer

EVP Liver Cirrhosis R&D

EVP Neuroscience R&D

EVP Liver Cirrhosis Programs

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the tre...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-04	Premium	bought	Premium	Premium	Premium	President & CEO
2023-12-11	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-01	Premium	sold	Premium	Premium	Premium	-
2023-11-30	Premium	bought	Premium	Premium	Premium	President & CEO
2023-11-09	Premium	acquired	Premium	Premium	Premium	-
2023-11-09	Premium	acquired	Premium	Premium	Premium	-
2023-11-09	Premium	acquired	Premium	Premium	Premium	-
2023-11-09	Premium	acquired	Premium	Premium	Premium	-
2023-09-05	Premium	sold	Premium	Premium	Premium	-
2023-08-22	Premium	sold	Premium	Premium	Premium	-
2023-06-29	Premium	acquired	Premium	Premium	Premium	CEO & President
2023-06-21	Premium	acquired	Premium	Premium	Premium	CEO & President
2023-06-07	Premium	sold	Premium	Premium	Premium	-
2023-05-22	Premium	sold	Premium	Premium	Premium	-
2023-03-28	Premium	sold	Premium	Premium	Premium	-
2023-03-27	Premium	sold	Premium	Premium	Premium	-
2023-02-16	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-02-16	Premium	sold (taxes)	Premium	Premium	Premium	EVP Neuroscience Product Dev.
2023-02-16	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-02-16	Premium	sold (taxes)	Premium	Premium	Premium	EVP Liver Cirrhosis R&D
2023-02-16	Premium	sold (taxes)	Premium	Premium	Premium	CEO & President
2023-02-16	Premium	sold (taxes)	Premium	Premium	Premium	EVP Neuroscience R&D
2022-11-23	Premium	acquired	Premium	Premium	Premium	-
2022-11-23	Premium	acquired	Premium	Premium	Premium	-
2022-11-23	Premium	acquired	Premium	Premium	Premium	EVP Neuroscience R&D

BIVI - BioVie Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for BIVI